Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Copper ions in GHK-Cu can inhibit up to 90% of type 1 5-alpha reductase, potentially reducing DHT-related follicle miniaturization without systemic hormonal effects
155 YuC.CunninghamM.RogersC.DinbergsI
GHK-Cu has accumulated one of the largest research profiles of any synthetic tripeptide, with studies spanning wound healing, tissue repair, inflammation, and gene regulation
Topical + microneedling (in-clinic): Peptides applied directly after microneedling penetrate dramatically deeper because microchannels bypass the stratum corneum
For research use only BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg (Glow) is supplied exclusively for in-vitro laboratory research and scientific investigation
The most commonly cited starting protocol in the medical literature and clinical practice involves 250 micrograms administered once daily for acute injury, stepping up to 500 micrograms daily if response is insufficient after one to two weeks
